Remission effect of Canagliflozin in patients with newly diagnosed type 2 diabetes mellitus: a protocol for a multicenter, parallel-group, randomized, controlled, open-label trial. - Yang, Xue; He, Zhiwei; Yuan, Li; Huang, Wenbin; Li, Doudou; Xiang, Pingping; Chen, Yu; Chen, Guofang; Liu, Chao (BMC Endocrine Disorders, 2023)